Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients
<p>Protein tyrosine phosphatase receptor gamma (PTPRG) is a member of the receptor-like family protein tyrosine phosphatases and acts as a tumor suppressor gene in different neoplasms. Recent studies reported the down-regulation of PTPRG expression levels in Chronic Myeloid Leukemia disease (C...
Saved in:
| Main Author: | Mohamed A. Ismail (418629) (author) |
|---|---|
| Other Authors: | Marzia Vezzalini (212801) (author), Hisham Morsi (14152881) (author), Ahmad Abujaber (9100064) (author), Ali Al Sayab (4166521) (author), Kodappully Siveen (3520073) (author), Mohamed A. Yassin (8361183) (author), Maria Monne (4166524) (author), Muthanna Samara (11619435) (author), Richard Cook (70389) (author), Claudio Sorio (212799) (author), Helmout Modjtahedi (532099) (author), Nader I. Al-Dewik (14152884) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Description of PTPRG genetic variants identified in a cohort of Chronic Myeloid Leukemia patients and their ability to influence response to Tyrosine kinase Inhibitors
by: Mohamed A. Ismail (418629)
Published: (2022) -
Safety and efficacy of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia: A protocol for systematic review and meta-analysis
by: Fateen Ata (12217764)
Published: (2022) -
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia
by: Luisa Tomasello (702932)
Published: (2020) -
The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
by: Bara A. Shraim (11753786)
Published: (2021) -
FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2
by: Rafael Jiménez-Izquierdo (19482373)
Published: (2023)